Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. - Wikidata - wikimedia - TriplyDB

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

http://www.wikidata.org/entity/Q34792600

about

Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90 A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I Hepatitis C virus proteins Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122 miR-122 continues to blaze the trail for microRNA therapeutics Systems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesis Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms Metabolic alterations and hepatitis C: From bench to bedside Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection Immune and non-immune responses to hepatitis C virus infection Hepatitis C virus infection and type 1 and type 2 diabetes mellitus Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases Future classes of hepatitis C virus therapeutic agents Robust hepatitis C virus infection in vitro.Molecular virology of hepatitis C virus (HCV): 2006 update Palmitoylation and Polymerization of Hepatitis C Virus NS4B Protein Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins Studying Hepatitis C Virus: Making the Best of a Bad Virus Bile Acids Promote the Expression of Hepatitis C Virus in Replicon-Harboring Cells Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway Using high-throughput genomics to study hepatitis C: What determines the outcome of infection?Hepatitis C virus replicons: dinosaurs still in business?Targeting host factors: A novel rationale for the management of hepatitis C virus Role of Oxysterol Binding Protein in Hepatitis C Virus infection Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor Do statins reduce hepatitis C RNA titers during routine clinical use?Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis An Interferon Regulated MicroRNA Provides Broad Cell-Intrinsic Antiviral Immunity through Multihit Host-Directed Targeting of the Sterol Pathway

P2860

Q21090530-945A3EB2-76CD-4DDC-9201-D5147DC26100 Q24305040-B83083F8-FF27-476A-A04A-7A8009E2FA1C Q24306116-E6046317-B066-4B5B-8E90-35F73175D1B4 Q24307609-BF194D0F-3D69-403D-824B-AA4A493F4608 Q24318935-5C14E8DE-43E5-4BE7-AF69-664B974D2B6A Q24338324-ED96B5E5-05DB-4A41-9A73-4A189849E0E5 Q24556673-B677DDF0-A2D5-4EC2-A280-339FE882A7C6 Q24563969-7C008102-371C-4FBD-BCE3-C40E2C3F4892 Q24609988-48F4A7A8-F038-4013-9BB9-FDA9E5A4EE27 Q24628313-D6B139F5-4F7F-41DA-A85A-D4B8179DD99A Q24631218-A05C33C2-5F2A-41F7-874C-78B853650727 Q24653950-7E9159F7-A4AF-4F00-A90A-8525B6EE2157 Q26773261-0B2B29D0-3AAA-4077-A9DF-CEF69219741A Q26779128-07B2F9F0-C2D8-44B3-8B9E-48434740F173 Q26782040-3189062A-A2C9-4CE7-8EF3-EE5B219D38E5 Q26829202-72AAA029-3E24-4DF2-A8CA-4746DC4F9CEB Q26861095-95EF7810-3261-4582-8F17-73FC13ED6F37 Q26992256-7EA1EEF9-A2AB-425E-AFB8-9BBC30DF6460 Q27009321-520AD2E7-B6EE-499D-9364-C39BCFB113D7 Q27470013-426F1FBE-4030-4D23-BACA-69CF4008B122 Q27473115-CC4DD213-4326-459A-8400-7B6E2FB13275 Q27473233-3361B989-EE29-4217-9D43-59E3A9631F3A Q27473258-9F3CD610-FA48-48FA-8DFC-9478DE316D35 Q27478188-B99A017C-C5C3-474B-B834-C98DD6A60964 Q27481034-F974BB01-9266-413A-9D96-DA47FF88BF64 Q27481465-92798037-A455-41A9-8325-D2A8CF2795D2 Q27484047-46314003-70FF-4571-951A-9C8C25719A1D Q27485487-9F86CAD1-6B75-44E5-BD73-D6A74813457A Q27488294-C43BB8C0-C892-40CC-80B9-C20AF0BB26DA Q27488407-99C87A2F-587E-4DE2-82FB-14607C32E0E3 Q27488905-7B26C722-B20F-4A66-9DF5-333DB812459F Q27488999-0FA01DB7-33C7-491A-87A0-9F0FAF2ECC14 Q27489539-D6E7CA92-FEDB-4268-B331-B5043DEF24EA Q27489697-DD325686-BF22-4268-847F-6EB8F7901A8B Q27490234-769EB729-FC85-4E70-827B-84E62D09FF5C Q27490248-E1336B79-770B-45BE-AFFD-AD82D41466C8 Q28081216-43F7F048-B6A0-4F91-90D2-5553DF3D4C53 Q28303547-1BFDDE9A-F85E-47C2-9939-2441D3997C5F Q28477369-BCFCBCD7-34A8-46DF-ADF4-2836ACF38300 Q28550521-C4D4969C-12A9-4F9F-9DAE-1DA506CA371F

P2860

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

http://www.wikidata.org/entity/Q34792600

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@ast

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@en

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@nl

type

label

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@ast

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@en

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@nl

prefLabel

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@ast

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@en

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@nl

P1433

Q34792600-08322BC0-FCC0-4D2E-B97C-A6FD607AB3F1

P1476

Q34792600-F91D80E6-5695-465F-8C13-892406565932

P2093

Q34792600-22CCCA21-EF86-4AD0-99D3-01C58020D7E8

Q34792600-25FA75E1-4777-47CF-AD16-57411E9EE240

Q34792600-336413B6-2FA2-4DA8-A4B5-D96A48B74FAD

Q34792600-5D08CF3C-4FB2-4BED-9088-C9ED74EC9C84

P2860

Q34792600-1136C6E0-EB8F-404E-928F-7416F72230B9

Q34792600-1E30A27E-B1A9-4640-82E4-74CF3D06BD98

Q34792600-2C6E03CC-B638-49E5-90A8-B916167B3495

Q34792600-2DAD917B-BF02-47A0-BA18-5310F2828226

Q34792600-371BEF46-94B4-48B3-887E-D84210BC316A

Q34792600-3953ABFA-5AC0-4D0A-9CCB-0F358DBB4DE4

Q34792600-4208800A-0DCB-4573-91C8-DFB2384183EA

Q34792600-45026CF6-5897-4EC1-8893-2144BDB5767A

Q34792600-48DB1EE7-4CA0-4F78-A09E-381F21857C1F

Q34792600-4A6C1F01-5A9A-41B2-AF4C-B5F87428297E

P304

Q34792600-9021FD3B-953D-4314-9064-E8E9C1CF5DCC

P31

Q34792600-D8DE1B45-F52A-43B7-9DF9-8EB465D472B6

P356

Q34792600-144838B0-38EF-476F-A035-22A1617FEB54

P407

Q34792600-81942045-95EF-41AC-AA2E-4DD3899C3BE6

P433

Q34792600-6112046D-F912-4DDE-8E25-C2BD912131AD

P478

Q34792600-591FB35A-1B78-45E8-9C97-E24F6D63B529

P50

Q34792600-2CD6BC32-4FF9-4036-9DAF-15CE8E039C87

Q34792600-E1D5AAF5-B357-4719-9D03-0658697A1B00

P577

Q34792600-E44ACFC1-1FBC-4B17-A8BB-AFC04EF5A5DE

P5875

Q34792600-9B872E3F-4668-41CE-9C90-924597127640

P698

Q34792600-584EE64D-2D81-4F63-B5E5-B41DD6CB1419

P932

Q34792600-45643A29-DA14-47D0-9A28-7910E26B09C0

P356

PNAS.2237238100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Disruption of hepatitis C viru ...... t protein geranylgeranylation.

@en

P2093

Chunfu Wang

http://www.w3.org/2001/XMLSchema#string

Jin Ye

http://www.w3.org/2001/XMLSchema#string

Michael S Brown

http://www.w3.org/2001/XMLSchema#string

Rhea Sumpter

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture

Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2

Nonstructural Protein Precursor NS4A/B from Hepatitis C Virus Alters Function and Ultrastructure of Host Secretory Apparatus

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

P304

15865-15870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.2237238100

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Joseph L. Goldstein

P577

2003-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8966466

http://www.w3.org/2001/XMLSchema#string

P698

14668447

http://www.w3.org/2001/XMLSchema#string

P932

307659

http://www.w3.org/2001/XMLSchema#string